Concepedia

Rolf Angerbauer

RA

Statistics

Publications

10

Citations

447

H-Index

10

Active since

1977

Affiliations

University of Konstanz(Current)

Bayer (Germany)

Rolf Angerbauer is an author at University of Konstanz specializing in biochemistry, pharmacology, and biochemical pharmacology.

Publications per year

1977–1998

10

Publications

10

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

Hilmar Bischoff, Rolf Angerbauer, Joachim Bender et al. · Atherosclerosis · 1997 · 109 citations

, , +6

Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved.

Michael Boberg, Rolf Angerbauer, Peter Fey et al. · PubMed · 1997 · 77 citations

, , +17

A convenient preparation of 2,3-unsaturated N-galactosyl derivatives

Richard R. Schmidt, Rolf Angerbauer · Carbohydrate Research · 1979 · 49 citations

, , +7

Simple <i>de‐novo</i> Synthesis of Reactive Pseudoglycals (Hex‐2‐enopyranosides)—Stereospecific α‐Glycoside Coupling

Richard R. Schmidt, Rolf Angerbauer · Angewandte Chemie International Edition in English · 1977 · 49 citations

, , +12

Biotransformation of cerivastatin in mice, rats, and dogs in vivo.

Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai et al. · PubMed · 1998 · 45 citations

, , +13

1–5 of 10